Categories: Business

J&J looks to buy Ollin Biosciences for up to $3.4 billion, FT says

Published by
TDG Syndication

Nov 15 (Reuters) – Johnson & Johnson could announce a deal as soon as Monday to buy Texas-based biotech Ollin Biosciences for up to $3.4 billion, the Financial Times said, citing people familiar with

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

TDG Syndication
Published by TDG Syndication